Dynavax Technologies (DVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Sales | 232,284 | 722,683 | 439,442 | 46,551 | 35,219 |
| Cost of Goods | 50,167 | 262,153 | 173,572 | 11,410 | 10,172 |
| Gross Profit | 182,117 | 460,530 | 265,870 | 35,141 | 25,047 |
| Operating Expenses | 219,312 | 177,161 | 131,956 | 103,922 | 160,062 |
| Operating Income | -37,028 | 283,522 | 134,486 | -68,371 | -134,843 |
| Interest Expense | 6,757 | 6,732 | 11,176 | 19,062 | 16,977 |
| Other Income | 39,418 | 17,509 | -45,789 | 12,193 | -780 |
| Pre-tax Income | -4,367 | 294,299 | 77,521 | -75,240 | -152,600 |
| Income Tax | 2,022 | 1,143 | 808 | 0 | N/A |
| Net Income Continuous | -6,389 | 293,156 | 76,713 | -75,240 | -152,600 |
| Net Income | $-6,389 | $293,156 | $76,713 | $-75,240 | $-152,600 |
| EPS Basic Total Ops | -0.05 | 2.32 | 0.62 | -0.75 | -2.16 |
| EPS Basic Continuous Ops | -0.05 | 2.32 | 0.66 | -0.75 | -2.12 |
| EPS Diluted Total Ops | -0.05 | 1.97 | 0.57 | -0.78 | -2.16 |
| EPS Diluted Continuous Ops | -0.05 | 1.94 | 0.58 | -0.74 | -2.12 |
| EPS Diluted Before Non-Recurring Items | -0.05 | 1.97 | 0.87 | -0.61 | -1.87 |
| EBITDA(a) | $-46,307 | $286,009 | $142,014 | $-58,501 | $-114,775 |